Pēteris Trapencieris

637 total citations
38 papers, 480 citations indexed

About

Pēteris Trapencieris is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Pēteris Trapencieris has authored 38 papers receiving a total of 480 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Organic Chemistry, 19 papers in Molecular Biology and 5 papers in Pharmacology. Recurrent topics in Pēteris Trapencieris's work include Synthesis and Catalytic Reactions (13 papers), Enzyme function and inhibition (6 papers) and Chemical Synthesis and Analysis (5 papers). Pēteris Trapencieris is often cited by papers focused on Synthesis and Catalytic Reactions (13 papers), Enzyme function and inhibition (6 papers) and Chemical Synthesis and Analysis (5 papers). Pēteris Trapencieris collaborates with scholars based in Latvia, Russia and Italy. Pēteris Trapencieris's co-authors include Edgars Sūna, Edwin Vedējs, Raivis Žalubovskis, Aiga Grandāne, S. Belyakov, Artūrs Ābols, Aija Linē, Kaspars Tārs, Ja̅nis Leita̅ns and Kristaps Jaudzems and has published in prestigious journals such as Philosophical Transactions of the Royal Society B Biological Sciences, International Journal of Molecular Sciences and The Journal of Organic Chemistry.

In The Last Decade

Pēteris Trapencieris

36 papers receiving 472 citations

Peers

Countries citing papers authored by Pēteris Trapencieris

Since Specialization

Citations

This map shows the geographic impact of Pēteris Trapencieris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pēteris Trapencieris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pēteris Trapencieris more than expected).

Fields of papers citing papers by Pēteris Trapencieris

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pēteris Trapencieris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pēteris Trapencieris. The network helps show where Pēteris Trapencieris may publish in the future.

Co-authorship network of co-authors of Pēteris Trapencieris

This figure shows the co-authorship network connecting the top 25 collaborators of Pēteris Trapencieris. A scholar is included among the top collaborators of Pēteris Trapencieris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pēteris Trapencieris. Pēteris Trapencieris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Pyrazole-based inhibitors of enhancer of zeste homologue 2 induce apoptosis and autophagy in cancer cells 2018 ·Philosophical Transactions of the Royal Society B Biological Sciences ·Paolo Mellini, Biagina Marrocco, (unknown), Lucia Polletta, Ilaria Carnevale, (unknown), Giulia Stazi, Clemens Zwergel, Pēteris Trapencieris, Elisabetta Ferretti, Marco Tafani, Sérgio Valente, Antonello Mai	18
2	Depletion of carbonic anhydrase IX abrogates hypoxia-induced overexpression of stanniocalcin-1 in triple negative breast cancer cells 2017 ·Cancer Biology & Therapy ·(unknown), Pawel Zayakin, Artūrs Ābols, (unknown), Pēteris Trapencieris, Aija Linē	15
3	The histone methyltransferase EZH2 as a druggable target in SHH medulloblastoma cancer stem cells 2017 ·Oncotarget ·Evelina Miele, Sérgio Valente, Vincenzo Alfano, Marianna Silvano, Paolo Mellini, (unknown), Biagina Marrocco, Agnese Pò, Zein Mersini Besharat, Giuseppina Catanzaro, Giuseppe Battaglia, Luana Abballe, Clemens Zwergel, Giulia Stazi, Ciro Milite, Sabrina Castellano, Marco Tafani, Pēteris Trapencieris, Antonello Mai, Elisabetta Ferretti	36
4	A Novel Aziridine-based Bruton’s Tyrosine Kinase Inhibitor Induces Apoptosis Through Down-regulation of p65/RelA Phosphorylation on Serine 536 and ERK1/2 in Mantle Cell Lymphoma 2016 ·Anticancer Research ·(unknown), (unknown), (unknown), (unknown), Pēteris Trapencieris	3
5	Structures of Plasmepsin II from Plasmodium Falciparum in Complex with Two Hydroxyethylamine-based Inhibitors 2015 ·publication.editionName ·Rosario Recacha, Ja̅nis Leita̅ns, Ināra Akopjana, (unknown), Pēteris Trapencieris, Kristaps Jaudzems	0
6	Structures of plasmepsin II fromPlasmodium falciparumin complex with two hydroxyethylamine-based inhibitors 2015 ·Acta Crystallographica Section F Structural Biology Communications ·Rosario Recacha, Ja̅nis Leita̅ns, Ināra Akopjana, (unknown), Pēteris Trapencieris, Kristaps Jaudzems, Aigars Jirgensons, Kaspars Tārs	16
7	Original paper Morphological and immunohistochemical profile of pancreatic neuroendocrine neoplasms 2015 ·Polish Journal of Pathology ·(unknown), (unknown), Ilze Štrumfa, Māris Sperga, (unknown), (unknown), Pēteris Trapencieris, Jānis Gardovskis	6
8	Prognostic relevance of carbonic anhydrase IX expression is distinct in various subtypes of breast cancer and its silencing suppresses self-renewal capacity of breast cancer cells 2014 ·Cancer Chemotherapy and Pharmacology ·(unknown), (unknown), Karīna Siliņa, Zane Kalniņa, Artūrs Ābols, Edgars Endzeliņš, (unknown), (unknown), (unknown), Pēteris Trapencieris, J. Eglītis, Aija Linē	48
9	5-Membered cyclic hydroxamic acids as HDAC inhibitors 2014 ·Journal of Enzyme Inhibition and Medicinal Chemistry ·Ilze Mutule, (unknown), (unknown), (unknown), Raivis Žalubovskis, Irīna Shestakova, Pēteris Trapencieris	10
10	Synthesis of Macromonocyclic Hydroxamic Acids* (Review) 2014 ·Chemistry of Heterocyclic Compounds ·(unknown), Philìppe Bertrand, Pēteris Trapencieris	4
11	A novel matrix metalloproteinase-2 inhibitor triazolylmethyl aziridine reduces melanoma cell invasion, angiogenesis and targets ERK1/2 phosphorylation 2013 ·Journal of Enzyme Inhibition and Medicinal Chemistry ·(unknown), Pēteris Trapencieris, (unknown), Māris Turks	10
12	SYNTHESIS OF MACROMONOCYCLIC HYDROXAMIC ACIDS 2013 ·Chemistry of Heterocyclic Compounds ·(unknown), Philìppe Bertrand, Pēteris Trapencieris	1
13	Acyl migration from N to C in aziridine-2-carboxylic esters 2013 ·Tetrahedron ·(unknown), (unknown), Sergey Belyakov, Pēteris Trapencieris	5
14	Discovery of aziridine-triazole conjugates as selective MMP-2 inhibitors 2013 ·Chemistry of Heterocyclic Compounds ·(unknown), (unknown), (unknown), Pēteris Trapencieris, (unknown), Māris Turks	8
15	Synthesis of small and medium size monocyclic hydroxamic acids 2012 ·Chemistry of Heterocyclic Compounds ·Pēteris Trapencieris, (unknown), Philìppe Bertrand	1
16	Synthesis of 6-sulfamoylsaccharin and study of its reactivity in alkylation reactions 2012 ·Chemistry of Heterocyclic Compounds ·Jekaterīna Ivanova, (unknown), (unknown), Pēteris Trapencieris, Raivis Žalubovskis	5
17	Unnatural Amino Acids. 2. Simple Method of Obtaining Esters of Aziridine-2-carboxylic Acids by a Transesterification Reaction 2004 ·Chemistry of Heterocyclic Compounds ·(unknown), Dmitri Chernyak, (unknown), (unknown), Pēteris Trapencieris	4
18	The Nenitzescu reaction: an initial screening of experimental conditions for improvment of the yield of a model reaction 2004 ·Journal of Chemometrics ·(unknown), Pēteris Trapencieris, (unknown), (unknown), Torbjörn Lundstedt	6
19	A convenient synthesis of 5β-cholestan-26-oic and 5β-cholestan-26,27-dioic acids 2000 ·Steroids ·(unknown), Pēteris Trapencieris, (unknown), Gerhard Jas, Ivars Kalvinsh	6
20	Substituted Isoquinolines by Noyori Transfer Hydrogenation: Enantioselective Synthesis of Chiral Diamines Containing an Aniline Subunit 1999 ·The Journal of Organic Chemistry ·Edwin Vedējs, Pēteris Trapencieris, Edgars Sūna	79

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact